LG Chem (051910) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
23 Jun, 2026Executive summary
Q3 2024 consolidated sales reached KRW 12.67 trillion, with operating profit at KRW 498 billion and an OP margin of 3.9%.
Net income for Q3 2024 was KRW 1,013 billion, a significant increase from Q2 2024.
Profitability improved due to Energy Solution's strong performance and stable advanced materials, while Petrochemicals and Farm Hannong faced margin pressures.
Sale of the polymer material business completed, boosting non-operating income.
Achieved consolidated revenue of ₩36.6 trillion for the first nine months of 2024, with LG Energy Solution contributing 52.4% of sales.
Financial highlights
Assets at Q3-end were KRW 80.8 trillion, liabilities KRW 43.2 trillion, and capital KRW 45.6 trillion.
Debt ratio increased to 94.7% due to higher borrowings.
Gross margin improved to 18.1% in Q3 2024 from 15.3% in Q2 2024.
Cash and equivalents increased to KRW 8.8 trillion at quarter-end.
Operating profit for the first nine months was ₩1.17 trillion, with net income attributable to controlling interests at ₩364.6 billion.
Outlook and guidance
CapEx for 2024 reduced from KRW 4 trillion to mid-KRW 2 trillion range due to market uncertainties.
Q4 expected to see improved profitability in petrochemicals from better spreads and utilization, but advanced materials and cathode sales to decline due to inventory adjustments and lower metal prices.
Full-year cathode shipments expected to rise 25% YOY, but ASP to fall 40% YOY, weakening profitability.
Energy Solution expects continued volume growth despite inventory adjustments and lower metal prices, driven by EV and ESS demand.
Life Sciences projects solid sales for major products, but R&D costs from global clinical trials will weigh on margins.
Latest events from LG Chem
- Q2 sales rose, but net income and guidance fell amid weak demand and higher costs.051910
Q2 202423 Jun 2026 - Q1 2025 saw improved profitability and strong battery sales amid ongoing market volatility.051910
Q1 202523 Jun 2026 - Operating profit improved, but net income was negative amid persistent market headwinds.051910
Q2 202523 Jun 2026 - Q3 2025 profitability rebounded on cost cuts and one-time gains, but outlook stays cautious.051910
Q3 202523 Jun 2026 - Q1 2026 saw strong sales but a net loss, with batteries and petrochemicals as key drivers.051910
Q1 202622 Jun 2026 - Lower 2024 profits and weak demand drive restructuring, cost control, and cautious investment.051910
Q4 202428 May 2026 - Accelerating growth in sustainability, battery materials, and new drugs to drive future value.051910
Corporate presentation20 May 2026 - Four growth drivers are set to triple their revenue share by 2030 through strategic restructuring.051910
Corporate presentation20 May 2026 - Driving global sustainability and innovation with advanced materials and life sciences.051910
Corporate presentation20 May 2026